BIOSENSE WEBSTER INC OCTARAY MAPPING CATHETER; CATHETER, INTRACARDIAC MAPPING, HIGH-DENSITY ARRAY
|
Back to Search Results |
|
Catalog Number D160903 |
Device Problems
Delivered as Unsterile Product (1421); Packaging Problem (3007)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/19/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with an octaray mapping catheter and the sterility of the device was compromised.It was reported that the octaray mapping catheter outer box/packaging was damaged, and the customer believed the contents sterility was compromised.They opened a new catheter to continue the case.The device was not used on the patient.The pouch seal did not appear to be open.The device was secured in the tray and there was no damage to the device.
|
|
Manufacturer Narrative
|
On (b)(6) 2023, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4) on 15-aug-2023, it was noticed the code of packaging problem (a0205) was inadvertently omitted from field h6.Medical device problem code in the 3500a initial mdr.The code has now been added.
|
|
Manufacturer Narrative
|
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with an octaray mapping catheter and the sterility of the device was compromised.It was reported that the octaray mapping catheter outer box/packaging was damaged, and the customer believed the contents sterility was compromised.They opened a new catheter to continue the case.The device was not used on the patient.The pouch seal did not appear to be open.The device was secured in the tray and there was no damage to the device.Device evaluation details: the device was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.A visual inspection evaluation of the returned device was performed following bwi procedures.Visual inspection revealed no damage or anomalies on the catheter; however, the packaging of the device was not returned, and for this reason, the product investigation could not be completed.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The event described could not be confirmed as the packaging was not returned.Although no product defect was identified, there may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Search Alerts/Recalls
|
|
|